OTCMKTS:ROSGQ Rosetta Genomics (ROSGQ) Stock Price, News & Analysis → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free ROSGQ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Rosetta Genomics alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About Rosetta Genomics Stock (OTCMKTS:ROSGQ)Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company's microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. ROSGQ Stock News HeadlinesJune 1, 2023 | msn.com10x Genomics files new EU patent suits against NanoString, VizgenMay 23, 2023 | msn.com10x Genomics launches big expansion with new Pleasanton officesMay 2, 2024 | Porter & Company (Ad)Truth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. May 22, 2023 | marketwatch.comTwist Bioscience Shares Rise 16% After Launch of RNA Sequencing ToolsMay 20, 2023 | it.tmcnet.comOMICSEDGE FORMS STRATEGIC PARTNERSHIP WITH ALMADEN GENOMICS TO STREAMLINE DRUG DISCOVERYMay 20, 2023 | msn.comTelo Genomics to raise $2M through private placement of unitsMay 9, 2023 | marketwatch.comGenomics And Proteomics Reagents, Research Kits And Analytical Instruments Market Share, Analysis, Size, and Forecast 2028May 9, 2023 | marketwatch.com2023-2030 Revenue of the Single Cell Genomics MarketMay 2, 2024 | Porter & Company (Ad)Truth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. May 7, 2023 | msn.comBlack History with Abolitionist and social reformer Rosetta Douglass Sprague (1839-1906) continued a family legacy of activism that began in New Bedford with her parents ...May 4, 2023 | msn.comLearn 25 Languages with a lifetime of Rosetta Stone and save $110May 3, 2023 | technews.tmcnet.com10x Genomics Reports First Quarter 2023 Financial ResultsApril 23, 2023 | nypost.comLearn with a lifetime subscription to Rosetta Stone, now only $162April 22, 2023 | msn.comLearn the language before you travel with a special discount on Rosetta StoneMarch 23, 2023 | marketwatch.comSquamous Cell Carcinoma Antigen Quantitative Determination Kit Market: Key Players and Strategies for Future Growth by 2023-2027March 23, 2023 | appleinsider.comThis Rosetta Stone deal drops lifetime access to just $144.97March 4, 2023 | msn.comRossetto helps Atlanta United earn 1-1 draw with TorontoFebruary 14, 2023 | marketwatch.comWhole Genome Sequencing Market Analysts Offer Insights on Chemical and Materials Industry CompaniesFebruary 11, 2023 | msn.comGene regulators that play a big role in type-2 diabetes identifiedFebruary 11, 2023 | finance.yahoo.comInsights on the Single Cell Genomics Global Market to 2027: Players Include 10x Genomics, 1CellBio, Agilent/Dako and Beckman Coulter DiagnosticsFebruary 10, 2023 | marketwatch.comInherited Cancer Genome Testing Market Research Report 2023 by Product, Application, End-users, Region And Global Forecast to 2028August 30, 2022 | reuters.comRosetta Genomics LtdJanuary 20, 2022 | nasdaq.comRosetta Genomics Ltd. (ROSGQ)August 19, 2021 | barrons.comRosetta Genomics Ltd.See More Headlines Receive ROSGQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rosetta Genomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:ROSGQ CUSIPN/A CIKN/A Webwww.rosettagenomics.com Phone972732220700Fax972-73-222-0701Employees86Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Douglas SitesExecutive Vice President of Sales & MarketingProf. Zvi Bentwich M.D.Deputy Chairman of the Scientific Advisory BoardKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors ROSGQ Stock Analysis - Frequently Asked Questions How do I buy shares of Rosetta Genomics? Shares of ROSGQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ROSGQ) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour bank is lying to you.MyBankTrackerForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rosetta Genomics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.